BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 30939820)

  • 1. Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects.
    Bassani B; Baci D; Gallazzi M; Poggi A; Bruno A; Mortara L
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30939820
    [No Abstract]   [Full Text] [Related]  

  • 2. A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.
    Bruno A; Ferlazzo G; Albini A; Noonan DM
    J Natl Cancer Inst; 2014 Aug; 106(8):dju200. PubMed ID: 25178695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.
    Rossi GR; Trindade ES; Souza-Fonseca-Guimaraes F
    Front Immunol; 2020; 11():73. PubMed ID: 32063906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases.
    Radomska-Leśniewska DM; Białoszewska A; Kamiński P
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment.
    Navin I; Lam MT; Parihar R
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NK Cells in Tumor Progression.
    Terrén I; Borrego F
    Exp Suppl; 2022; 113():169-187. PubMed ID: 35165864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between macrophages and natural killer cells in the tumor microenvironment.
    Zhou J; Zhang S; Guo C
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108374. PubMed ID: 34824036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell exhaustion in the tumor microenvironment.
    Jia H; Yang H; Xiong H; Luo KQ
    Front Immunol; 2023; 14():1303605. PubMed ID: 38022646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.
    Gras Navarro A; Björklund AT; Chekenya M
    Front Immunol; 2015; 6():202. PubMed ID: 25972872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms' Tumors.
    Pelosi A; Fiore PF; Di Matteo S; Veneziani I; Caruana I; Ebert S; Munari E; Moretta L; Maggi E; Azzarone B
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells.
    Albini A; Gallazzi M; Palano MT; Carlini V; Ricotta R; Bruno A; Stetler-Stevenson WG; Noonan DM
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
    Mahaweni NM; Bos GMJ; Mitsiades CS; Tilanus MGJ; Wieten L
    Cancer Immunol Immunother; 2018 Jun; 67(6):861-872. PubMed ID: 29500635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
    Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
    Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress.
    Hasmim M; Messai Y; Ziani L; Thiery J; Bouhris JH; Noman MZ; Chouaib S
    Front Immunol; 2015; 6():482. PubMed ID: 26441986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype.
    Lee CL; Vijayan M; Wang X; Lam KKW; Koistinen H; Seppala M; Li RHW; Ng EHY; Yeung WSB; Chiu PCN
    Hum Reprod; 2019 Apr; 34(4):689-701. PubMed ID: 30597092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategical consideration of the interaction between tumor microenvironment and tumor immunity].
    Fujiwara H
    Rinsho Ketsueki; 2018; 59(10):1895-1904. PubMed ID: 30305490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell-mediated immunosurveillance of human cancer.
    Malmberg KJ; Carlsten M; Björklund A; Sohlberg E; Bryceson YT; Ljunggren HG
    Semin Immunol; 2017 Jun; 31():20-29. PubMed ID: 28888619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the tumor microenvironment (TME) by melatonin.
    Mu Q; Najafi M
    Eur J Pharmacol; 2021 Sep; 907():174365. PubMed ID: 34302814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.